These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24929326)

  • 21. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
    Si JG; Su YY; Han YH; Chen RH
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Mo S; Su Z; Heng B; Chen W; Shi L; Du X; Lai C
    J Nippon Med Sch; 2018; 85(2):78-86. PubMed ID: 29731501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Wnt antagonist sFRP1 in colorectal tumorigenesis.
    Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG
    Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.
    Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B
    Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Pasha HF; Radwan MI; Yehia AM; Toam MM
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant promoter methylation of SOCS-1 gene may contribute to the pathogenesis of hepatocellular carcinoma: a meta-analysis.
    Zhao RC; Zhou J; He JY; Wei YG; Qin Y; Li B
    J BUON; 2016; 21(1):142-51. PubMed ID: 27061542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancer.
    Zhang YW; Miao YF; Yi J; Geng J; Wang R; Chen LB
    Neoplasma; 2010; 57(3):228-33. PubMed ID: 20353273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SFRP1 promoter methylation and expression in human trabecular meshwork cells.
    Mao W; Rubin JS; Anoruo N; Wordinger RJ; Clark AF
    Exp Eye Res; 2012 Apr; 97(1):130-6. PubMed ID: 22248913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of toll-like receptor 4 in colorectal carcinogenesis: a meta-analysis.
    Li XX; Sun GP; Meng J; Li X; Tang YX; Li Z; Wang MF; Liang GF; Lu XB
    PLoS One; 2014; 9(4):e93904. PubMed ID: 24705379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.
    Fang C; Wei XM; Zeng XT; Wang FB; Weng H; Long X
    BMC Cancer; 2015 Nov; 15():920. PubMed ID: 26585467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis.
    Jiang JL; Tian GL; Chen SJ; Xu LI; Wang HQ
    Exp Ther Med; 2015 Oct; 10(4):1549-1555. PubMed ID: 26622524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.
    Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z
    Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines.
    Ye M; Huang T; Li J; Zhou C; Yang P; Ni C; Chen S
    Medicine (Baltimore); 2017 Jan; 96(4):e5956. PubMed ID: 28121942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.].
    Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma.
    Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z
    Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of CDH1 promoter polymorphism and DNA methylation in bladder carcinogenesis: a meta-analysis.
    Wang Y; Kong CZ; Zhang Z; Yang CM; Li J
    DNA Cell Biol; 2014 Apr; 33(4):205-16. PubMed ID: 24491043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.